Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats

Nephrology

Volumn 19, Issue 9, 2014, Pages 542-551

  Wang, Fang Ming ^a   Yang, Yu Jie ^a   Ma, Lu Lin ^a   Tian, Xiao Jun ^a   He, Ya Qiang ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

berberine; fibrosis; oxidative stress; rats; ureteral obstruction

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BERBERINE; CATALASE; CREATININE; MALONALDEHYDE; SMAD3 PROTEIN; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; ACTIN; AUTACOID; BIOLOGICAL MARKER; MADH3 PROTEIN, RAT; SMOOTH MUSCLE ACTIN, RAT; TGFB1 PROTEIN, RAT; URINARY TRACT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; EXPERIMENTAL RENAL FIBROSIS; HYDRONEPHROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY BLOOD FLOW; MALE; NONHUMAN; OXIDATIVE STRESS; PERCUTANEOUS NEPHROSTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL INTERSTITIAL FIBROSIS; RESISTIVE INDEX; TREATMENT DURATION; UNILATERAL URETERAL OBSTRUCTION; UREA NITROGEN BLOOD LEVEL; URETER OBSTRUCTION; URINALYSIS; URINE VOLUME; WEIGHT GAIN; WESTERN BLOTTING; ANIMAL; CELL PROTECTION; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; HEMODYNAMICS; KIDNEY; KIDNEY CIRCULATION; KIDNEY DISEASES; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TIME; URETERAL OBSTRUCTION; VASCULARIZATION;

ACTINS; ANIMALS; BERBERINE; BIOLOGICAL MARKERS; CATALASE; CYTOPROTECTION; DISEASE MODELS, ANIMAL; FIBROSIS; HEMODYNAMICS; HYDRONEPHROSIS; INFLAMMATION MEDIATORS; KIDNEY; KIDNEY DISEASES; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; SUPEROXIDE DISMUTASE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION; UROLOGICAL AGENTS;

EID: 84906702283     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12271     Document Type: Article

References (27)

1. Liu Y,. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int. 2006; 69: 213-217.
2. Mazzei LJ, García IM, Altamirano L, Docherty NG, Manucha W,. Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat. Am. J. Nephrol. 2012; 35: 103-113.
3. Zeisberg M, Neilson EG,. Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 2010; 21: 1819-1834.
4. Bascands JL, Schanstra JP,. Obstructive nephropathy: Insights from genetically engineered animals. Kidney Int. 2005; 68: 925-937.
5. Wang W, Koka V, Lan HY,. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005; 10: 48-56.
6. Ha H, Lee HB,. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology (Carlton) 2005; 10 (Suppl): S7-10.
7. Ozbek E, Ilbey YO, Ozbek M, Simsek A, Cekmen M, Somay A,. Melatonin attenuates unilateral ureteral obstruction-induced renal injury by reducing oxidative stress, iNOS, MAPK, and NF-kB expression. J. Endourol. 2009; 23: 1165-1173.
8. Imanshahidi M, Hosseinzadeh H,. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother. Res. 2008; 22: 999-1012.
9. Sun X, Zhang X, Hu H, et al. Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis. Biol. Pharm. Bull. 2009; 32: 1533-1537.
10. Chitra P, Saiprasad G, Manikandan R, Sudhandiran G,. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: A biphasic experimental study. Toxicol. Lett. 2013; 219: 178-193.
11. Huang K, Liu W, Lan T, et al. Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models. PLoS ONE 2012; 7: e43874.
12. Kilic S, Altinok MT, Ipek D, Beytur A, Baydinc YC, Günes G,. Color Doppler sonography examination of partially obstructed kidneys associated with ureteropelvic junction stone before and after percutaneous nephrolithotripsy: preliminary report. Int. J. Urol. 2005; 12: 429-435.
13. Mizuno S, Matsumoto K, Nakamura T,. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int. 2001; 59: 1304-1314.
14. Mizuguchi Y, Miyajima A, Kosaka T, Asano T, Asano T, Hayakawa M,. Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. J. Urol. 2004; 172: 2456-2459.
15. Lin SL, Kisseleva T, Brenner DA, Duffield JS,. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 2008; 173: 1617-1627.
16. Zhang Y, Zhang JE, Xiao HQ, Wu PY, Bai SJ,. Gypenosides inhibit renal fibrosis by regulating expression of related genes in rats with unilateral ureteral obstruction. J. Nephrol. 2011; 24: 112-118.
17. Schnell D, Darmon M,. Renal Doppler to assess renal perfusion in the critically ill: A reappraisal. Intensive Care Med. 2012; 38: 1751-1760.
18. Demirbilek S, Emre MH, Aydin EN, et al. Sulfasalazine reduces inflammatory renal injury in unilateral ureteral obstruction. Pediatr. Nephrol. 2007; 22: 804-812.
19. Sugiyama H, Kobayashi M, Wang DH, et al. Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol. Dial. Transplant. 2005; 20: 2670-2680.
20. Paller MS, Hoidal JR, Ferris TF,. Oxygen free radicals in ischemic acute renal failure in the rat. J. Clin. Invest. 1984; 74: 1156-1164.
21. Nilakantan V, Maenpaa C, Jia G, Roman RJ, Park F,. 20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells. Am. J. Physiol. Renal Physiol. 2008; 294: F562-570.
22. Annuk M, Zilmer M, Lind L, Linde T, Fellström B,. Oxidative stress and endothelial function in chronic renal failure. J. Am. Soc. Nephrol. 2001; 12: 2747-2752.
23. Ucero AC, Benito-Martin A, Izquierdo MC, et al. Unilateral ureteral obstruction: Beyond obstruction. Int. Urol. Nephrol. 2014; 46: 765-776.
24. Okusa MD, Linden J, Huang L, Rosin DL, Smith DF, Sullivan G,. Enhanced protection from renal ischemia-reperfusion [correction of ischemia: reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition. Kidney Int. 2001; 59: 2114-2125.
25. Inazaki K, Kanamaru Y, Kojima Y, etal. Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int. 2004; 66: 597-604.
26. Fan JM, Ng YY, Hill PA, etal. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int. 1999; 56: 1455-1467.
27. Qi HW, Xin LY, Xu X, Ji XX, Fan LH,. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis. J. Transl. Med. 2014; 24: 12-22.